Synthesis of controlled-size silver nanoparticles for the administration of methotrexate drug and its activity in colon and lung cancer cells-Reference-Cited by-同舟云学术

Synthesis of controlled-size silver nanoparticles for the administration of methotrexate drug and its activity in colon and lung cancer cells

Published:2020 Issue:18 Volume:10 Page:10646-10660
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Rozalen M.¹²³⁴⁵^ORCID,Sánchez-Polo M.¹²³⁴⁵,Fernández-Perales M.¹²³⁴⁵,Widmann T. J.⁶⁷⁸⁹¹⁰,Rivera-Utrilla J.¹²³⁴⁵

Affiliation:

1. Department of Inorganic Chemistry

2. Faculty of Science

3. University of Granada

4. 18071 Granada

5. Spain

6. Department of Genomic Medicine

7. GENYO

8. Centre for Genomics & Oncology (Pfizer - University of Granada & Andalusian Regional Government)

9. PTS Granada

10. Granada 18016

Abstract

A controlled synthesis of methotrexate (MTX) silver nanoparticles (AgNPs-MTX) using borohydride and citrate as reduction and reduction/capping agents, respectively, was performed in order to obtain AgNPs-MTX conjugates with a narrow size distribution.

Funder

Ministerio de Ciencia e Innovación

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/C9RA08657A

Reference35 articles.

1. In Vivo Targeted Delivery of Nanoparticles for Theranosis

2. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

3. Silver nanoparticles as a new generation of antimicrobials